Impaired G protein function in gallbladder muscle from progesterone-treated guinea pigs.
This study was designed to elucidate the mechanism of action of progesterone on gallbladder smooth muscle in guinea pigs. Adult male guinea pigs were treated with either progesterone (2 mg.kg-1.day-1) or saline for 7 days. Gallbladder muscle cells were isolated by enzymatic digestion with collagenase. Contractile responses to agonists were expressed as percent shortening from control cell length. [35S]guanosine 5'-O-(3-thiotriphosphate) ([35S]GTP gamma S)-binding properties of G proteins were assessed in crude membranes of gallbladder muscle with or without cholecystokinin octapeptide (CCK-8) stimulation. Gallbladder muscle cells from progesterone-treated guinea pigs exhibited an impaired contractile response to CCK-8, GTP gamma S, or aluminum fluoride but a normal response to potassium chloride or D-myo-inositol 1,4,5-trisphosphate compared with controls. Western blot analysis of gallbladder muscle revealed the presence of Gi1-2, Gi3, Gq/11, and Gs proteins. The maximal contraction induced by CCK-8 was blocked by pertussis toxin and Gi alpha 3-specific antibodies, but not by Gi alpha 1-2 or Gq/11 alpha antibodies. CCK-8 caused a significant increase in [35S]GTP gamma S binding to Gi alpha 3, but not to Gq/11 alpha or Gi alpha 1-2. The stimulation of Gi alpha 3 binding, however, was significantly reduced in gallbladder muscle membranes from progesterone-treated guinea pigs compared with that in control animals. In conclusion, progesterone might cause gallbladder hypomotility by downregulating Gi3 proteins.
Chen
Q
Q
Department of Medicine, Rhode Island Hospital, Providence, USA.
Chitinavis
V
V
Xiao
Z
Z
Yu
P
P
Oh
S
S
Biancani
P
P
Behar
J
J
D017607:Aluminum Compounds / Q000494:pharmacology; D000818:Animals; D002766:Cholecystokinin / Q000502:physiology; D005459:Fluorides / Q000494:pharmacology; D019204:GTP-Binding Proteins / Q000502:physiology*; D005704:Gallbladder / Q000502:physiology*; D006168:Guinea Pigs; D015544:Inositol 1,4,5-Trisphosphate / Q000494:pharmacology; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology*; D009130:Muscle, Smooth / Q000502:physiology*; D037342:Pertussis Toxin; D011374:Progesterone / Q000494:pharmacology / Q000502:physiology*; D015398:Signal Transduction; D012844:Sincalide / Q000494:pharmacology; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
D017607:Aluminum Compounds; D010566:Virulence Factors, Bordetella; D011374:Progesterone; D015544:Inositol 1,4,5-Trisphosphate; D002766:Cholecystokinin; D037342:Pertussis Toxin; D019204:GTP-Binding Proteins; D012844:Sincalide; D005459:Fluorides; C032311:aluminum fluoride